Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：24

作者：

Bansal, Amar D. ^{[1
]}

Hill, Chloe E. ^{[2
]}

Berns, Jeffrey S. ^{[1
]}

机构：

[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期

关键词：

GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;

D O I：

10.1111/sdi.12385

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.

引用

页码：404 / 412

页数：9

共 50 条

[1] Exercise for children with chronic kidney disease and end-stage renal disease
Clapp, Emma L.
Bevington, Alan
Smith, Alice C.
PEDIATRIC NEPHROLOGY, 2012, 27 (02) : 165 - 172
[2] Pregnancy in advanced chronic kidney disease and end-stage renal disease
Alkhunaizi, Ahd
Melamed, Nir
Hladunewich, Michelle A.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (03) : 252 - 259
[3] Anticancer Drugs in End-Stage Kidney Disease Patients
Janus, Nicolas
Launay-Vacher, Vincent
SEMINARS IN DIALYSIS, 2015, 28 (04) : 413 - 416
[4] Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation
Jagdale, Abhijit
Cooper, David K. C.
Iwase, Hayato
Gaston, Robert S.
XENOTRANSPLANTATION, 2019, 26 (02)
[5] Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges
Vilay, A. Mary
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 61 - 71
[6] Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with hemodialysis
Kimmel, PL
Patel, SS
SEMINARS IN NEPHROLOGY, 2006, 26 (01) : 68 - 79
[7] Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease
Mathew, Roy O.
Bettinger, Jeffrey J.
Wegrzyn, Erica L.
Fudin, Jeffrey
JOURNAL OF PAIN RESEARCH, 2016, 9 : 1191 - 1195
[8] A wearable artificial kidney for patients with end-stage renal disease
Gura, Victor
Rivara, Matthew B.
Bieber, Scott
Munshi, Raj
Smith, Nancy Colobong
Linke, Lori
Kundzins, John
Beizai, Masoud
Ezon, Carlos
Kessler, Larry
Himmelfarb, Jonathan
JCI INSIGHT, 2016, 1 (08)
[9] Risk of Peptic Ulcer Bleeding in Patients with Chronic Kidney Disease and End-Stage Renal Disease Receiving Peritoneal or Hemodialysis
Tomoyuki Kawada
Digestive Diseases and Sciences, 2014, 59 : 3131 - 3132
[10] Development and Validation of a Uremic Pruritus Treatment Algorithm and Patient Information Toolkit in Patients With Chronic Kidney Disease and End Stage Kidney Disease
Ragazzo, Jessica
Cesta, Annemarie
Jassal, S. Vanita
Chiang, Nicholas
Battistella, Marisa
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 59 (02) : 279 - +

← 1 2 3 4 5 →